The EBODAC project (Ebola Vaccine Deployment, Acceptance and Compliance) is developing strategies and tools to promote the acceptance and uptake of new Ebola vaccines, to help the right person receive the right vaccine at the right time.

EBODAC is important because the successful development and deployment of an Ebola vaccine is faced with many challenges, especially when working in resource limited settings. These include:

Supporting EBOVAC-Salone

EBODAC is working to ensure the prime-boost vaccine regimen is well accepted and successfully used in the context of clinical trials; while also preparing to maximise the impact of the potential deployment of a future Ebola vaccination programme in West Africa.

EBODAC is currently supporting the EBOVAC-Salone clinical trial in Kambia District, Sierra Leone, and is using this opportunity to evaluate the three levers it has developed:

All components of the EBODAC platform are designed and developed to allow rapid scale-up should there be a need to eventually deploy a licensed vaccine.

Sharing expertise

The EBODAC consortium is committed to sharing the expertise and lessons learned from using community engagement, communication and technology while conducting clinical trials related to Ebola in an outbreak setting. In February 2017 EBODAC organised a symposium on this theme in Dakar, Senegal, which brought together experts from across Africa and beyond. The learnings from the symposium have contributed to a training resource which is now available as an open-access tool for anybody who is conducting, or interested in, community engagement for clinical trials in outbreak settings

Learn more

Learn more about EBODAC with our short Introduction to EBODAC animation.

These projects have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement EBOVAC1 (grant nr. 115854), EBOVAC2 (grant nr. 115861), EBOMAN (grant nr. 115850) and EBODAC (grant nr. 115847). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations (EFPIA).
Copyright © 2018 Ebovac | Terms and Conditions | WordPress development by Toast.